Anti-cancer activity elucidation of geissolosimine as an MDM2-p53 interaction inhibitor: An in-silico study - Md. Al-Amin; Rehnuma Tanjin; Md. Rasul Karim; Jannatul Mawa Etee; Ayesha Siddika; Nafisa Akter; Md. Helal Uddin; Ratul Mahmud; Tasfia Saffat; Md. Faruk Hossen; Samira Idris Mowlee; Elmu Kabir Rafa; et al. (PLoS ONE, 2025)